Skip to content
Screener

Price / book at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
3.9×-0.5×
Corcept Therapeutics logo
Corcept TherapeuticsCORT
13.2×+0.4×
MBX Biosciences, Inc. logo
MBX Biosciences, Inc.MBX
3.2×+2.2×
XER
Xeris Biopharma Holdings, Inc.XERS
76.9×
Viking Therapeutics logo
Viking TherapeuticsVKTX
7.5×+4.3×
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
8.3×+4.9×

Other financials

Income statement

See full
Revenue$10.7M+2,873%
Gross profit$10.5M+2,818%
Operating income-$140.4M-26.0%
Net income-$127.8M-32.1%
EPS (diluted)-$1.23-18.3%

Balance sheet

See full
Cash & equivalents$115.1M+20.1%
Total debt$47.9M-5.8%
Total equity$1.3B+2.1%
Total assets$1.4B+2.9%

Cash flow

See full
Operating cash flow-$124.7M-41.0%
CapEx$820.0K-33.8%
Free cash flow-$125.5M-40.0%

Valuation

See full
Market cap$8.9B+233%
Enterprise value$8.84B+231%
P/S492.8×-1,427×

Profitability

See full
Gross margin150%-15.6pp
Operating margin-3,020.3%-1,463pp
Net margin-2,747.2%-1,328pp
FCF margin-2,321.7%-1,122pp

Returns & leverage

See full
Return on equity-39.2%+14.5pp
Debt / equity0.0×
Current ratio18.6×-3.9×

Where this comes from

Calculated from Crinetics Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 4:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001658247-26-000040

FAQ

What is Crinetics Pharmaceuticals's price / book?
Crinetics Pharmaceuticals (CRNX) reported price / book of 3× in Q1 2026.
How has Crinetics Pharmaceuticals's price / book changed year-over-year?
Crinetics Pharmaceuticals's price / book increased by 19.3% year-over-year, from 2.5× to 3×.
What is the long-term trend for Crinetics Pharmaceuticals's price / book?
Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's price / book has grown at a 2.3% compound annual growth rate (CAGR), from 4× to 4.5×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Crinetics Pharmaceuticals's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude